GHK-Cu is a short chain of three amino acids bound to copper, and its side effects are not well mapped because the research is thin. This guide explains GHK-Cu side effects as the research record reports them, in plain language. It covers what the name means, how the compound is thought to work on skin and hair, what the studies found, and what remains untested. It describes research only and is not advice for any person. For a closer look at what the compound is studied for, see the GHK-Cu benefits guide.
What Is GHK-Cu and What Does GHK Stand For?
GHK stands for the three amino acids that make up the peptide, which are glycine, histidine, and lysine. A peptide is simply a short chain of amino acids, the small building blocks that proteins are made from. The “Cu” is the chemical symbol for copper. GHK-Cu is the form of this peptide that is holding on to a copper atom, which is why it is sometimes called a copper peptide.
According to Wikipedia, GHK-Cu was first isolated from human blood plasma in 1973. The body makes it naturally, and the amount in plasma is about 200 ng/ml at age 20 and about 80 ng/ml by age 60. A nanogram (ng) is a billionth of a gram. Synthetic GHK-Cu is also used in cosmetics.
How Does GHK-Cu Work on Skin and Hair?
A 2026 review in Archives of Internal Medicine Research explains that GHK is released from collagen, the main support protein in skin, when tissue is injured. It holds copper tightly, and copper is needed by a family of enzymes that link collagen fibers together. An enzyme is a protein that speeds up a chemical job in the body. Those links help give skin its strength.
In lab studies on skin cells, GHK-Cu has been linked to several effects. These include changes in the enzymes that break down skin proteins and the enzymes that block that breakdown. Wikipedia notes that GHK-Cu raises both kinds, and says this suggests it should be used with caution. The same review also describes lab findings about skin stem cells, which are the cells that renew the outer skin layer, and about calming inflammation.
Hair research is thinner. A 2026 review in Pharmaceutics mentions a study of 18 people that reported cosmetic hair benefits, but it did not define the exact form of GHK-Cu used or how much reached the skin. One more point is useful to know. GHK-Cu dissolves easily in water, which makes it hard to push through the oily outer layer of skin. A 2015 study in Pharmaceutical Research found almost no peptide or copper crossed intact human skin in 9 hours. After the skin was pretreated with tiny needles called microneedles, 134 nanomoles of peptide and 705 nanomoles of copper crossed. A nanomole is a billionth of a mole, a unit chemists use to count molecules. This was a lab skin model, and it shows that how a product is applied changes how much gets in.
See also: How Peptides Took Over the Skincare Industry
GHK-Cu Side Effects at a Glance
The key point about safety is how little direct evidence exists. No study in the sources reviewed was built to measure the side effects of GHK-Cu itself. The table sums up what the research record does and does not show.
| Area | What the research reports | How solid is it |
|---|---|---|
| Skin irritation from creams or serums | Skin cell tests found low irritation compared with simple copper salts. The study summaries reviewed here do not describe irritation | Low. Lab cells and small studies |
| Skin darkening | A 2025 split-face acne scar study flagged a pigmentation risk, as described in a 2026 review | Low. Second-hand report |
| Injected use | FDA lists possible immune reactions for injectable routes, and says safety data are limited | Limited |
| Too much copper | Excess copper is harmful in general. Whether GHK-Cu adds to this has not been measured | Not measured |
| Long-term use | No long-term safety study was found | None |
Many consumer websites list mild redness, tingling, dryness, or breakouts as side effects. The trial summaries and reviews used for this guide do not describe those effects, so this guide cannot confirm them. The research record leaves the side-effect profile uncertain rather than showing that no side effects exist.
What Research Reports About GHK-Cu Benefits
This guide focuses on side effects, but the benefit claims explain why the compound is studied at all. The findings are small and early.
- Wrinkles. In a small 2016 pilot study described in the Archives review, a topical serum reduced wrinkle volume by 55.8 percent and wrinkle depth by 32.8 percent at 8 weeks compared with a plain base. The study was small, and the review notes that few trials exist.
- Acne scars. In a 2025 split-face study, one side of the face got a roller treatment alone and the other got the roller plus a GHK-Cu serum at 0.5 to 1 percent. The GHK-Cu side showed an early advantage, but by week 16 the two sides were comparable.
- Skin after laser resurfacing. A 2006 trial in Archives of Facial Plastic Surgery had 13 people use GHK-Cu skin care after laser resurfacing. A 2026 review in Pharmaceutics notes it found no gain on objective measures.
- Hair. A 2018 pilot study in the Journal of Cosmetic and Laser Therapy gave 1,000 people scalp injections of a mixture of growth factors and a copper peptide. Because the mixture had several ingredients, the result cannot be credited to GHK-Cu alone.
A 2026 review in Aesthetic Surgery Journal found only 2 randomized trials among 20 studies. A randomized trial splits people into groups by chance, which is the fairest way to compare a treatment with a comparison. For a full discussion, see the GHK-Cu benefits guide and the peptides for skin guide.
See also: Glutathione Peptide and What Antioxidant Research Shows
What Is Known About GHK-Cu Safety?
Safety has not been established. It would require large, long, well-controlled studies, and those do not exist for GHK-Cu. A 2026 review in Archives of Internal Medicine Research, covering 2005 to 2026, says the literature remains thin and fragmented, and that most randomized trials are small and done on facial cosmetic creams. A 2026 review in Pharmaceutics says the clinical evidence remains sparse.
The route of use matters a great deal. On the skin, little GHK-Cu crosses intact skin, as the 2015 study above shows. Injection skips the skin barrier, so more material gets in, and the data are thinner still. A 2026 review in the American Journal of Sports Medicine found no clinical data supporting GHK-Cu for muscle, bone, or joint problems, and said that dosing, frequency, and duration of peptide treatments remain unknown.
FDA has looked at the injected route specifically. Its page on bulk drug substances used in compounding lists GHK-Cu for injectable routes among substances that were nominated and later withdrawn by the nominators, after being placed in a category for possible significant safety risks. FDA wrote that injectable products may pose a risk of immune reactions, because peptides can clump together and carry impurities from manufacturing, and that there are limited data to inform safety. The page was current as of April 2026. Questions about regulatory status should go to qualified regulatory or legal advisers.
The other big question is copper itself. According to Wikipedia, the body needs copper to work, but too much can cause copper toxicity, and long-term excess can damage the liver and kidneys. People with Wilson’s disease, an inherited condition, cannot clear copper normally. Healthy bodies regulate copper tightly, and the half-life of copper in the body is about 13 to 33 days. A half-life is the time it takes for half of an amount to clear.
What Clinical Studies Report About GHK-Cu Safety
The table lists what individual studies do and do not tell us about tolerability.
| Study | What it covered | What it says about tolerability |
|---|---|---|
| 2006 trial, Archives of Facial Plastic Surgery | 13 people used GHK-Cu skin care after laser skin resurfacing | Looked at redness, wrinkles, and satisfaction. The summary does not describe side effects |
| 2016 cell study, Scientific Reports | Skin cells treated with GHK-Cu or two simple copper salts | GHK-Cu was not toxic to the cells and did not raise irritation markers. The copper salts did at the same strengths |
| 2015 skin model study, Pharmaceutical Research | GHK-Cu pushed through skin pretreated with microneedles | No obvious signs of skin irritation. This was a lab skin model |
| 2025 split-face study, as described in a 2026 review | Roller treatment alone versus roller plus GHK-Cu serum for acne scars | Authors flagged a risk of skin darkening on the GHK-Cu side |
| 2018 pilot study, Journal of Cosmetic and Laser Therapy | 1,000 people got scalp injections of a mixture of growth factors and a copper peptide | Authors called it well tolerated. The mixture had several ingredients, so it cannot be credited to GHK-Cu alone |
| 2002 lab study, Bulletin of Experimental Biology and Medicine | Ten injections of the GHK peptide, without copper, in lab models | Raised liver cell division and lowered immune responses in a dose-dependent way |
Three findings frame the copper question.
- Binding may help. A 2024 study in Metallomics found that GHK binds copper, lowers copper’s harmful chemical activity, and protected cells in a dish from copper and zinc toxicity. The authors said free metal ions can be harmful.
- The form of copper matters. In the 2016 skin cell study, GHK-Cu did not trigger irritation markers, while copper chloride and copper acetate did at the same strengths. The authors concluded GHK-Cu has a low potential for irritation compared with those salts.
- Products can differ. The 2026 Pharmaceutics review says the literature often treats GHK-Cu as a single ingredient, even though products vary in how the copper is bound, how stable they are, and how toxic they are. Delivery studies often leave out how much copper is loose and whether intact GHK-Cu or its pieces were released.
Several large gaps remain. None of the sources reviewed describes long-term safety studies of GHK-Cu. The Pharmaceutics review says an ongoing phase 2 wound study has no results yet and cannot be used as evidence, and the Aesthetic Surgery Journal review calls for larger, controlled trials with standard formulations. The Archives review also says about 35 percent of the GHK-Cu primary literature in its window includes Loren Pickart or Anna Margolina as an author, and that this concentration limits independence. Because of these gaps, an absence of reported problems should not be read as proof of safety.
GHK-Cu Dosage in Published Research
There is no established amount of GHK-Cu, and the research record does not set one for safety purposes. The 2026 American Journal of Sports Medicine review says dosing, frequency, and duration remain unknown. Studies have used very different forms and strengths, which makes them hard to compare. A few examples show the range.
- Skin cell studies. The 2016 Badenhorst work described in the Archives review used very small strengths of 0.01, 1, and 100 nanomolar on skin cells in a dish.
- Skin model study. The 2015 microneedle study measured what crossed the skin, namely 134 nanomoles of peptide and 705 nanomoles of copper.
- Split-face study. The 2025 acne scar study used a serum of 0.5 to 1 percent together with a roller.
These figures describe what individual studies used. They are not instructions, and they do not mean any amount is safe. Amounts and concentrations quoted on commercial websites are not backed by the trials reviewed here. For lab work, a batch-specific Certificate of Analysis that states the form and the copper content is especially useful. The peptide reconstitution guide and the GHK-Cu dosage and reconstitution guide cover general laboratory steps.
See also: Peptide Reconstitution Ratios & How to Calculate Them
Frequently Asked Questions
What are the side effects of GHK-Cu?
The research record does not give a clear list. The sources reviewed describe few safety findings, mostly low irritation in skin cell studies, a pigmentation flag in one acne scar study, and a pilot study of a mixture called well tolerated.
Is GHK-Cu safe?
That has not been established. Trials are small, mostly on cosmetic creams, and FDA says data on injectable routes are limited.
What does GHK-Cu stand for?
GHK stands for the amino acids glycine, histidine, and lysine. Cu is the symbol for copper.
Why does copper matter for GHK-Cu side effects?
Copper is essential in small amounts but harmful in excess. How much a product carries, and how much is loose, can change how toxic it is.
Is topical GHK-Cu different from injected GHK-Cu?
Yes. Little GHK-Cu crosses intact skin, while injection skips that barrier. The injected route has the thinner data and the FDA concern about immune reactions.
Has GHK-Cu been tested in large trials?
No large independent trial appears in the reviews used for this guide.
Key Takeaways
- Direct evidence is thin. No study reviewed was built to measure GHK-Cu side effects.
- Skin use. Skin cell and skin model studies show low irritation, but little GHK-Cu may cross intact skin. One acne scar study flagged possible skin darkening.
- Injected use. Data are limited, and FDA flagged possible immune reactions for injectable routes.
- Copper. The copper part is the main safety question, and the form of copper matters.
- Dosage. No established amount exists, and figures in studies are not instructions.
- Gaps. Long-term safety, large independent trials, and product definition remain open.
Research Use Disclaimer
This content is provided for Research Use Only (RUO). The compounds discussed are not drugs, dietary supplements, foods, or cosmetics, and are not intended for human or animal consumption, diagnostic use, or therapeutic use of any kind. They have not been evaluated by the FDA for safety or efficacy in humans. Any research use must be conducted by qualified professionals in a controlled laboratory environment, in accordance with all applicable institutional, local, and federal regulations.
Sources
- Wikipedia contributors. Copper peptide GHK-Cu. Wikipedia, The Free Encyclopedia.
- Wikipedia contributors. Copper toxicity. Wikipedia, The Free Encyclopedia.
- Mateescu DM, Gavrilescu DM, et al. GHK-Cu as a bioactive metallopeptide and drug-delivery cargo, coordination chemistry, formulation science, therapeutic evidence, and a translational roadmap. Pharmaceutics. 2026.
- Najafi N, Maatouk H, et al. A systematic review of the mechanisms and therapeutic applications of GHK-Cu in topical microneedle delivery, a case for expanded clinical trials. Arch Intern Med Res. 2026.
- Mokhtar J, Mohamad B, et al. The regenerative potential of GHK-Cu in aesthetic medicine. Aesthet Surg J. 2026.
- Mortazavi SM, Mohammadi Vadoud SA, Moghimi HR. Topically applied GHK as an anti-wrinkle peptide, advantages, problems and prospective. Bioimpacts. 2025.
- Li H, Low YS, Chong HP, et al. Microneedle-mediated delivery of copper peptide through skin. Pharm Res. 2015.
- Li H, Toh PZ, Tan JY, et al. Selected biomarkers revealed potential skin toxicity caused by certain copper compounds. Sci Rep. 2016.
- Min JH, Sarlus H, Harris RA. Glycyl-l-histidyl-l-lysine prevents copper- and zinc-induced protein aggregation and central nervous system cell death in vitro. Metallomics. 2024.
- Miller TR, Wagner JD, Baack BR, Eisbach KJ. Effects of topical copper tripeptide complex on CO2 laser-resurfaced skin. Arch Facial Plast Surg. 2006.
- Kapoor R, Shome D. Intradermal injections of a hair growth factor formulation for enhancement of human hair regrowth, safety and efficacy evaluation in a first-in-man pilot clinical study. J Cosmet Laser Ther. 2018.
- Smakhtin MY, Sever’yanova LA, Konoplya AI, Shveinov IA. Tripeptide Gly-His-Lys is a hepatotropic immunosuppressor. Bull Exp Biol Med. 2002.
- Mayfield CK, Bolia IK, et al. Injectable peptide therapy, a primer for orthopaedic and sports medicine physicians. Am J Sports Med. 2026.
- U.S. Food and Drug Administration. Certain bulk drug substances for use in compounding that may present significant safety risks. Content current as of April 22, 2026.
Explore the anti-aging research category for related research compounds. For related reading, see the GHK-Cu benefits guide, the GHK-Cu dosage guide, the peptides for skin guide, and the BPC-157 side effects guide.